Hepatology

The FIB-4 index may not reliably detect liver fibrosis in MASLD, with high false-positive and false-negative rates, highlighting challenges for primary care screening.

Menstrual recovery after liver transplantation may indicate better graft liver health, as women whose periods returned were far less likely to develop liver complications.

New study finds cfDNA fragmentome analysis can detect liver disease early, identify fibrosis and cirrhosis, and even predict survival across illnesses.

Mouse study finds impaired ammonia clearance can accelerate hepatocellular carcinoma growth and highlights potential dietary strategies to slow tumours.

Post-COVID chronic liver complications, including fibrosis and cirrhosis, have been reported months after infection, highlighting long-term risks.

Multicentre study in South America suggests MASLD is a leading cause of cirrhosis, highlighting rising metabolic risk factors and gender-balanced insights.

Abnormal Wnt signalling may drive a rare, high-risk childhood liver cancer and influence chemotherapy response, new research suggests.

Genetically higher FGF21 levels were associated with lower problematic alcohol use, fewer binge episodes, reduced weekly alcohol intake, and lower ARLD risk.